Chesterfield, MO, United States of America

John F Schindler

USPTO Granted Patents = 6 


 

Average Co-Inventor Count = 3.6

ph-index = 3

Forward Citations = 14(Granted Patents)


Location History:

  • Larchmont, NY (US) (1991)
  • Chesterfield, MO (US) (2013 - 2016)

Company Filing History:


Years Active: 1991-2016

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Absolutely, here is the article you requested:

Title: John F. Schindler: A Trailblazer in Innovation

Introduction:

John F. Schindler, a remarkable figure in the world of inventors, hailing from Chesterfield, MO, showcases a passion for innovation that sets him apart. With a creative drive and a vision for meaningful change, Schindler has become a standout inventor in his field.

Latest Patents:

Schindler boasts an impressive portfolio of 5 patents, with his latest inventions revolving around substituted pyridinone-pyridinyl compounds. These innovative compounds hold promise in treating p38 kinase-mediated diseases like lymphomas and auto-inflammatory conditions. The pharmaceutical compositions and treatment methods outlined in his patents exhibit his dedication to advancing healthcare solutions.

Career Highlights:

Currently employed at Confluence Life Sciences, Inc., Schindler's expertise and innovative mindset shine through in his work. His contributions in developing novel compounds for disease treatment have garnered recognition within the industry, solidifying his position as a leading inventor.

Collaborations:

Close collaborators of John F. Schindler include Shaun Raj Selness and Joseph B. Monahan. Together, these driven individuals have pushed the boundaries of innovation, working towards creating impactful solutions in the medical field.

Conclusion:

In conclusion, John F. Schindler's unwavering commitment to innovation and his drive to make a difference through his inventions exemplify his exemplary role in the world of inventors. With a keen focus on addressing critical healthcare needs, Schindler continues to inspire and pave the way for transformative advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…